Skip to content

13F-HR filed by Royalty Pharma Sub-Manager, LLC

Royalty Pharma Sub-Manager, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 19:56:59 UTC, with 4 holding rows worth $196,268,588.

Accession
0002081668-26-000021
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 4 entries on the cover page, a total value of $196,268,588 stated on the cover page (in dollars after the unit check, H1), rows summing to $196,268,588 with VALUE read as dollars as filed, 13F file number 028-26787. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CYTOKINETICS INC23282W605COM NEW980,392$64,617,637dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock2,388,150$64,408,406dollars as filed
BIOHAVEN LTDG1110E107COM2,936,507$39,202,368dollars as filed
KAILERA THERAPEUTICS INC482931102COMMON STOCK2,455,357$28,040,177dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002081668-26-000021this filing2026-11-13